Market Overview:
The global oncology devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, technological advancements in oncology devices, and rising demand for minimally invasive procedures. Based on type, the rachytherapy devices segment is expected to account for the largest share of the global oncology devices market in 2018. This segment is projected to grow at a CAGR of 8% from 2018 to 2030. The growth in this segment can be attributed to the increasing use of rachytherapy as a treatment modality for various types of cancer. Based on application, cancer research institutes are expected to account for the largest share of the global oncology devices market in 2018.
Product Definition:
Oncology Devices are used in the diagnosis and treatment of cancer. They include devices such as x-ray machines, chemotherapy drugs, and radiation therapy machines.
Rachytherapy Devices:
Rachytherapy is a radiation therapy used to treat cancer. It's majorly used for prostate, cervical, lung and breast cancers. The treatment involves placing radioactive materials inside the body which then emit radiation on command by the medical practitioner. Rachytherapy can be done in two ways: external beam and intraoperative radiotherapy.
Endoscopic Devices:
Endoscopic devices are medical devices used for visualizing and removing objects from the body. These include cameras, forceps, snare wires, stethoscopes (hearing aids), thermometers, laparoscopes (surgery), cannula & suction pumps and other accessories.
Application Insights:
The cancer research institutes segment dominated the global oncology devices market in 2017. This can be attributed to factors such as increasing government funding for cancer research and rising prevalence of cancer across the globe. According to WHO, an estimated 9.6 million people died from cancer in 2016, which represented 22% of all deaths worldwide. In addition, an estimated 1.7 million people were diagnosed with new cases of lung, breast and colorectal cancers that year globally (excluding China).
Cancer hospitals are anticipated to witness lucrative growth over the forecast period owing to increasing number of approvals for novel equipment by regulatory authorities such as FDA (U.S.) and European Commission (EU) pertaining to chemoradiation therapy (CRT), robotic surgery systems and image-guided radiation therapy systems among others over the past few years due to technological advancements coupled with continuous R&D initiatives by major players such as Siemens Healthineers LLC; Stryker Corporation; GE Healthcare Ltd.
Regional Analysis:
North America dominated the global oncology devices market in 2017. This can be attributed to presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and government support for cancer research & development. For instance, as per the National Cancer Institute (NCI), there were 1.9 million new cases of cancer reported in the U.S., with prostate being most commonly diagnosed followed by breast and lung cancers.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for oncology devices market. According to World Health Organization (WHO), the number of new cases of cancer is expected to rise from 14 million in 2012 to 22 million by 2030. This will create demand for oncology devices and boost the growth of this market.
- Rising awareness about early detection and treatment: There is an increasing awareness among people about early detection and treatment options for cancer, which is driving the demand for oncology devices. People are now more inclined towards seeking medical help at an early stage, which is resulting in increased adoption of oncology devices.
- Technological advancements: The technological advancements in oncology devices are helping healthcare professionals to detect and treat cancers at an earlier stage, thus improving patient outcomes significantly. This is fuelling the growth of this market considerably across the globe.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oncology Devices Market Research Report
By Type
Rachytherapy Devices, Endoscopic Devices
By Application
Cancer Research Institutes, Cancer Hospitals
By Companies
GE Healthcare, Medtronic, Varian Medical Systems, Elekta, Theragenics Corporation, Accuray, Elekta, Theragenics Corporation, Eckert & Ziegler BEBIG
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Oncology Devices Market Report Segments:
The global Oncology Devices market is segmented on the basis of:
Types
Rachytherapy Devices, Endoscopic Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Research Institutes, Cancer Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Medtronic
- Varian Medical Systems
- Elekta
- Theragenics Corporation
- Accuray
- Elekta
- Theragenics Corporation
- Eckert & Ziegler BEBIG
Highlights of The Oncology Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Rachytherapy Devices
- Endoscopic Devices
- By Application:
- Cancer Research Institutes
- Cancer Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oncology Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oncology devices are medical devices used in oncology treatments. They include radiation therapy machines, chemotherapy drugs, and other equipment used to fight cancer.
Some of the key players operating in the oncology devices market are GE Healthcare, Medtronic, Varian Medical Systems, Elekta, Theragenics Corporation, Accuray, Elekta, Theragenics Corporation, Eckert & Ziegler BEBIG.
The oncology devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oncology Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oncology Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oncology Devices Market - Supply Chain
4.5. Global Oncology Devices Market Forecast
4.5.1. Oncology Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oncology Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oncology Devices Market Absolute $ Opportunity
5. Global Oncology Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oncology Devices Market Size and Volume Forecast by Type
5.3.1. Rachytherapy Devices
5.3.2. Endoscopic Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oncology Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oncology Devices Market Size and Volume Forecast by Application
6.3.1. Cancer Research Institutes
6.3.2. Cancer Hospitals
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oncology Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oncology Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oncology Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oncology Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oncology Devices Demand Share Forecast, 2019-2029
9. North America Oncology Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oncology Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oncology Devices Market Size and Volume Forecast by Application
9.4.1. Cancer Research Institutes
9.4.2. Cancer Hospitals
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oncology Devices Market Size and Volume Forecast by Type
9.7.1. Rachytherapy Devices
9.7.2. Endoscopic Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oncology Devices Demand Share Forecast, 2019-2029
10. Latin America Oncology Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oncology Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oncology Devices Market Size and Volume Forecast by Application
10.4.1. Cancer Research Institutes
10.4.2. Cancer Hospitals
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oncology Devices Market Size and Volume Forecast by Type
10.7.1. Rachytherapy Devices
10.7.2. Endoscopic Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oncology Devices Demand Share Forecast, 2019-2029
11. Europe Oncology Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oncology Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oncology Devices Market Size and Volume Forecast by Application
11.4.1. Cancer Research Institutes
11.4.2. Cancer Hospitals
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oncology Devices Market Size and Volume Forecast by Type
11.7.1. Rachytherapy Devices
11.7.2. Endoscopic Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Aalysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oncology Devices Demand Share, 2019-2029
12. Asia Pacific Oncology Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oncology Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oncology Devices Market Size and Volume Forecast by Application
12.4.1. Cancer Research Institutes
12.4.2. Cancer Hospitals
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oncology Devices Market Size and Volume Forecast by Type
12.7.1. Rachytherapy Devices
12.7.2. Endoscopic Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oncology Devices Demand Share, 2019-2029
13. Middle East & Africa Oncology Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oncology Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oncology Devices Market Size and Volume Forecast by Application
13.4.1. Cancer Research Institutes
13.4.2. Cancer Hospitals
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oncology Devices Market Size and Volume Forecast by Type
13.7.1. Rachytherapy Devices
13.7.2. Endoscopic Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oncology Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Oncology Devices Market: Market Share Analysis
14.2. Oncology Devices Distributors and Customers
14.3. Oncology Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Varian Medical Systems
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Elekta
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Theragenics Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Accuray
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Elekta
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Theragenics Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Eckert & Ziegler BEBIG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
